These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 17391572)
1. Biological markers as outcome measures for Alzheimer's disease interventions--real problems and future possibilities. Takeda M; Okochi M; Tagami S; Tanaka T; Kudo T Int Psychogeriatr; 2007 Jun; 19(3):391-400. PubMed ID: 17391572 [TBL] [Abstract][Full Text] [Related]
2. Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity. Hampel H; Mitchell A; Blennow K; Frank RA; Brettschneider S; Weller L; Möller HJ J Neural Transm (Vienna); 2004 Mar; 111(3):247-72. PubMed ID: 14991453 [TBL] [Abstract][Full Text] [Related]
3. Disease-modifying therapies for Alzheimer disease: challenges to early intervention. Cummings JL; Doody R; Clark C Neurology; 2007 Oct; 69(16):1622-34. PubMed ID: 17938373 [TBL] [Abstract][Full Text] [Related]
4. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020. Hampel H; Lista S; Teipel SJ; Garaci F; Nisticò R; Blennow K; Zetterberg H; Bertram L; Duyckaerts C; Bakardjian H; Drzezga A; Colliot O; Epelbaum S; Broich K; Lehéricy S; Brice A; Khachaturian ZS; Aisen PS; Dubois B Biochem Pharmacol; 2014 Apr; 88(4):426-49. PubMed ID: 24275164 [TBL] [Abstract][Full Text] [Related]
5. Genetic markers for diagnosis and pathogenesis of Alzheimer's disease. Kim DH; Yeo SH; Park JM; Choi JY; Lee TH; Park SY; Ock MS; Eo J; Kim HS; Cha HJ Gene; 2014 Jul; 545(2):185-93. PubMed ID: 24838203 [TBL] [Abstract][Full Text] [Related]
14. Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria. Wimo A; Ballard C; Brayne C; Gauthier S; Handels R; Jones RW; Jonsson L; Khachaturian AS; Kramberger M J Intern Med; 2014 Mar; 275(3):304-16. PubMed ID: 24605810 [TBL] [Abstract][Full Text] [Related]
15. [Early evaluation of Alzheimer's disease: biomarkers and neuropsychological tests]. Lanfranco RG; Manríquez-Navarro P; Avello LG; Canales-Johnson A Rev Med Chil; 2012 Sep; 140(9):1191-200. PubMed ID: 23354643 [TBL] [Abstract][Full Text] [Related]
16. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease. Teipel SJ; Grothe M; Lista S; Toschi N; Garaci FG; Hampel H Med Clin North Am; 2013 May; 97(3):399-424. PubMed ID: 23642578 [TBL] [Abstract][Full Text] [Related]
17. Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease. Teipel SJ; Sabri O; Grothe M; Barthel H; Prvulovic D; Buerger K; Bokde AL; Ewers M; Hoffmann W; Hampel H J Alzheimers Dis; 2013; 33 Suppl 1():S329-47. PubMed ID: 22735677 [TBL] [Abstract][Full Text] [Related]
18. [Near a biological diagnosis of Alzheimer's disease and related disorders]. Krolak-Salmon P; Seguin J; Perret-Liaudet A; Desestret V; Vighetto A; Bonnefoy M Rev Med Interne; 2008 Oct; 29(10):785-93. PubMed ID: 18584921 [TBL] [Abstract][Full Text] [Related]
19. Imaging is superior to cognitive testing for early diagnosis of Alzheimer's disease. Zamrini E; De Santi S; Tolar M Neurobiol Aging; 2004; 25(5):685-91. PubMed ID: 15172748 [TBL] [Abstract][Full Text] [Related]